Theraclone Sciences' Series B - II Round

Theraclone Sciences raised a round of funding on March 22, 2010.

Theraclone Sciences, formerly Spaltudaq, is a biotechnology company focused on the development of novel therapeutic antibodies for the treatment of infectious disease and cancer. The companys technolo…

Articles about Theraclone Sciences' Series B - II Round: